IDRSF
Price
$2.40
Change
+$0.15 (+6.67%)
Updated
Jun 27 closing price
Capitalization
592.71M
INTI
Price
$0.05
Change
+$0.01 (+25.00%)
Updated
Jul 2 closing price
Capitalization
8.27M
Interact to see
Advertisement

IDRSF vs INTI

Header iconIDRSF vs INTI Comparison
Open Charts IDRSF vs INTIBanner chart's image
Idorsia AG
Price$2.40
Change+$0.15 (+6.67%)
Volume$457
Capitalization592.71M
Inhibitor Therapeutics
Price$0.05
Change+$0.01 (+25.00%)
Volume$1.5K
Capitalization8.27M
IDRSF vs INTI Comparison Chart in %
Loading...
IDRSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDRSF vs. INTI commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDRSF is a Hold and INTI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (IDRSF: $2.40 vs. INTI: $0.05)
Brand notoriety: IDRSF and INTI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDRSF: 49% vs. INTI: 6%
Market capitalization -- IDRSF: $592.71M vs. INTI: $8.27M
IDRSF [@Biotechnology] is valued at $592.71M. INTI’s [@Biotechnology] market capitalization is $8.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDRSF’s FA Score shows that 0 FA rating(s) are green whileINTI’s FA Score has 0 green FA rating(s).

  • IDRSF’s FA Score: 0 green, 5 red.
  • INTI’s FA Score: 0 green, 5 red.
According to our system of comparison, IDRSF is a better buy in the long-term than INTI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDRSF’s TA Score shows that 2 TA indicator(s) are bullish while INTI’s TA Score has 3 bullish TA indicator(s).

  • IDRSF’s TA Score: 2 bullish, 1 bearish.
  • INTI’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, IDRSF is a better buy in the short-term than INTI.

Price Growth

IDRSF (@Biotechnology) experienced а +6.67% price change this week, while INTI (@Biotechnology) price change was +0.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDRSF($593M) has a higher market cap than INTI($8.27M). IDRSF YTD gains are higher at: 182.353 vs. INTI (-20.133). INTI has higher annual earnings (EBITDA): -3.56M vs. IDRSF (-189.01M). IDRSF has more cash in the bank: 64.8M vs. INTI (4.32M). INTI has less debt than IDRSF: INTI (84.3K) vs IDRSF (1.25B). IDRSF has higher revenues than INTI: IDRSF (161M) vs INTI (0).
IDRSFINTIIDRSF / INTI
Capitalization593M8.27M7,169%
EBITDA-189.01M-3.56M5,314%
Gain YTD182.353-20.133-906%
P/E Ratio4.54N/A-
Revenue161M0-
Total Cash64.8M4.32M1,499%
Total Debt1.25B84.3K1,487,544%
FUNDAMENTALS RATINGS
IDRSF vs INTI: Fundamental Ratings
IDRSF
INTI
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
55
Fair valued
PROFIT vs RISK RATING
1..100
10098
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
3561
P/E GROWTH RATING
1..100
9890
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INTI's Valuation (55) in the null industry is in the same range as IDRSF (81). This means that INTI’s stock grew similarly to IDRSF’s over the last 12 months.

INTI's Profit vs Risk Rating (98) in the null industry is in the same range as IDRSF (100). This means that INTI’s stock grew similarly to IDRSF’s over the last 12 months.

INTI's SMR Rating (98) in the null industry is in the same range as IDRSF (100). This means that INTI’s stock grew similarly to IDRSF’s over the last 12 months.

IDRSF's Price Growth Rating (35) in the null industry is in the same range as INTI (61). This means that IDRSF’s stock grew similarly to INTI’s over the last 12 months.

INTI's P/E Growth Rating (90) in the null industry is in the same range as IDRSF (98). This means that INTI’s stock grew similarly to IDRSF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IDRSFINTI
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
70%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 4 days ago
65%
MACD
ODDS (%)
Bullish Trend 4 days ago
58%
Bullish Trend 4 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
57%
Bullish Trend 4 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
51%
Bullish Trend 4 days ago
68%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 7 days ago
87%
BollingerBands
ODDS (%)
N/A
Bullish Trend 5 days ago
77%
Aroon
ODDS (%)
Bullish Trend 4 days ago
44%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
IDRSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TWQAX15.690.12
+0.77%
Transamerica Large Cap Value A
TLOTX9.690.06
+0.62%
Transamerica Large Value Opps I3
FIDZX38.010.22
+0.58%
Fidelity Advisor Intl Cap App Z
DWUSX17.290.07
+0.41%
DFA World ex US Targeted Val Instl
TGRYX12.38-0.01
-0.08%
TCW Global Real Estate N

IDRSF and

Correlation & Price change

A.I.dvisor tells us that IDRSF and CADL have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IDRSF and CADL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDRSF
1D Price
Change %
IDRSF100%
N/A
CADL - IDRSF
25%
Poorly correlated
+2.20%
NDTP - IDRSF
22%
Poorly correlated
N/A
ANNX - IDRSF
22%
Poorly correlated
+2.85%
HRTX - IDRSF
21%
Poorly correlated
+2.33%
LGVN - IDRSF
21%
Poorly correlated
+0.77%
More

INTI and

Correlation & Price change

A.I.dvisor indicates that over the last year, INTI has been loosely correlated with TENX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if INTI jumps, then TENX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INTI
1D Price
Change %
INTI100%
N/A
TENX - INTI
44%
Loosely correlated
+1.22%
BCDA - INTI
35%
Loosely correlated
+1.73%
ASPHF - INTI
24%
Poorly correlated
N/A
IVEVF - INTI
17%
Poorly correlated
N/A
IDRSF - INTI
6%
Poorly correlated
N/A
More